US Bancorp
CSTL icon

US Bancorp’s Castle Biosciences CSTL Stock Holding History

US Bancorp’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26K Buy
92
+44
+92% +$1.44K ﹤0.01% 3776
2025
Q4 		$1.87K Buy
48
+22
+85% +$709 ﹤0.01% 3770
2025
Q3 		$592 Buy
+26
New +$528 ﹤0.01% 3860
2025
Q2 		– Sell
-24
Closed -$480 – 4189
2025
Q1 		$480 Sell
24
-1,178
-98% -$29.2K ﹤0.01% 4045
2024
Q4 		$32K Sell
1,202
-3,413
-74% -$104K ﹤0.01% 2951
2024
Q3 		$132K Buy
4,615
+4,383
+1,889% +$112K ﹤0.01% 2253
2024
Q2 		$5.05K Sell
232
-234
-50% -$5.21K ﹤0.01% 3510
2024
Q1 		$10.3K Buy
466
+165
+55% +$3.59K ﹤0.01% 3328
2023
Q4 		$6.5K Buy
301
+23
+8% +$405 ﹤0.01% 3451
2023
Q3 		$4.7K Sell
278
-1
-0.4% -$17 ﹤0.01% 3448
2023
Q2 		$3.83K Buy
279
+40
+17% +$811 ﹤0.01% 3551
2023
Q1 		$5.43K Buy
239
+19
+9% +$464 ﹤0.01% 3497
2022
Q4 		$5.18K Sell
220
-3,363
-94% -$78K ﹤0.01% 3501
2022
Q3 		$93K Sell
3,583
-9,224
-72% -$259K ﹤0.01% 2226
2022
Q2 		$281K Sell
12,807
-3,661
-22% -$85.1K ﹤0.01% 1729
2022
Q1 		$739K Buy
16,468
+3,694
+29% +$153K ﹤0.01% 1326
2021
Q4 		$547K Sell
12,774
-816
-6% -$42.6K ﹤0.01% 1481
2021
Q3 		$904K Buy
13,590
+10,151
+295% +$714K ﹤0.01% 1234
2021
Q2 		$252K Buy
3,439
+2,829
+464% +$187K ﹤0.01% 1873
2021
Q1 		$42K Buy
+610
New +$45.8K ﹤0.01% 2662

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

US Bancorp's CSTL Position: Q1 2026 in Review

US Bancorp increased its Castle Biosciences (CSTL) stake by 92% in Q1 2026, buying an estimated $1.44K and bringing the position to 92 shares worth $2.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

US Bancorp first reported a position in CSTL in Q1 2021 and has held it in 20 quarters since. The position peaked at $904K in Q3 2021. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • US Bancorp held 92 shares of Castle Biosciences worth $2.26K as of Q1 2026.
  • US Bancorp bought 44 Castle Biosciences shares in Q1 2026, an estimated $1.44K.
  • Castle Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3776 holding.
  • US Bancorp first reported a position in Castle Biosciences in Q1 2021 and has held it in 20 quarters since.
  • US Bancorp's Castle Biosciences position peaked at $904K in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.